Manta Eleni, Iliakis Panagiotis, Fragoulis Christos, Leontsinis Ioannis, Stamoulopoulos Ioannis, Chrysohoou Christina, Tsioufis Konstantinos
First Department of Cardiology, Hippokration General Hospital, Medical School, National and Kapodistrian University of Athens, 114 Vasilissis Sofias Avenue, 11527 Athens, Greece.
Nutrients. 2025 Apr 3;17(7):1250. doi: 10.3390/nu17071250.
Obesity can cause the onset of heart failure and exacerbate the status of the pre-existing disease. Through intricate pathways, obesity activates hormonal factors that encourage the development of inflammation and lead to increased congestion. Consequently, this complex parallel pathophysiological cascade contributes to the echocardiographic and clinical signs of heart failure. In these patients, obesity frequently coexists with nutritional and muscular profile abnormalities that manifest as cachexia or sarcopenia. Patients with heart failure have a higher chance of surviving when obesity is treated. Interventional, pharmaceutical, and dietary strategies are used as forms of therapy. This review delves into the evaluation of the relationship between obesity and heart failure, and it targets to highlight the therapeutical impact of weight-loss programs on cardiac function in individuals with heart failure and obesity.
肥胖可导致心力衰竭的发生,并使已患疾病的病情加重。通过复杂的途径,肥胖会激活一些激素因子,这些因子会促使炎症发展并导致充血增加。因此,这种复杂的平行病理生理级联反应导致了心力衰竭的超声心动图和临床体征。在这些患者中,肥胖常与表现为恶病质或肌肉减少症的营养和肌肉状况异常同时存在。治疗肥胖时,心力衰竭患者存活的几率更高。干预措施、药物治疗和饮食策略都被用作治疗方式。这篇综述深入探讨了肥胖与心力衰竭之间关系的评估,旨在强调减肥计划对肥胖合并心力衰竭患者心脏功能的治疗影响。